03-14-2005: Researchers from Boston University School of Medicine (BUSM), University of Texas Southwestern Medical Center at Dallas (UT Southwestern), and SEQUENOM, Inc. report the discovery of a genetic variation that is the strongest known risk factor associated for age-related macular degeneration
(AMD).
"Considering that AMD is such a common and complex condition with multiple risk factors, we did not expect that we would identify a gene that is responsible for almost half of the cases," said author Lindsay A. Farrer, PhD, chief of the genetics program at BUSM, and a professor of medicine, neurology, genetics and genomics, epidemiology and biostatistics at BUSM.
The biological basis of this disorder, which is the most common cause of blindness in the elderly, is unclear. However, it was strongly suspected that genetics did play a role. The researchers tested single nucleotide polymorphisms (SNPs) for association of AMD in a region of 14 million base
pairs on chromosome 1q25-31 where a gene for AMD had been previously localized in families with multiple persons affected with AMD. Using two independent case-control populations, the researchers found that possession of at least one copy of histidine at position 402 of complement factor H (CFH) increased the risk of AMD almost three-fold.
"We are pleased to be part of this important collaboration with BU School of Medicine and UT Southwestern and that the use of our MassARRAY(R) System in this large-scale association study helped contribute to the discovery of the genetic variations associated with AMD," stated Charles Cantor, Ph.D. SEQUENOM's Chief Scientific Officer. "We recognize that the identified genetic targets may be suitable for molecular diagnostic purposes."
Original Publication: "Complement Factor H Polymorphism and Age-Related Macular
Degeneration"; Science online 2005.
Sequenom, Inc. announced the appointment of Suber Huang, M.D., to its ophthalmology clinical advisory board.Dr. Huang is President of the American Society of Retina Specialists and has served on the Steering Committee for the National Eye Health Education Program, an advisory board to the ... more
Sequenom, Inc. announced it has partnered with LifeCodexx AG for the commercialization of prenatal laboratory testing services in Europe. The companies have agreed to collaborate in the development and launch of a trisomy 21 laboratory developed test and other aneuploidies testing in German ... more
Sequenom, Inc. announced that it has commenced an exchange offer to acquire all of the outstanding shares of common stock of EXACT Sciences Corporation in an all-stock exchange valued at approximately $41 million. Subject to the terms and conditions of the offer, each share of EXACT Scien ... more
Researchers at Boston University working with collaborators in Germany, France and Korea have developed a nanoscale torsion resonator that measures miniscule amounts of twisting or torque in a metallic nanowire. This device, the size of a speck of dust, might enable measurements of the untw ... more
The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry for 2008 jointly to Osamu Shimomura, Marine Biological Laboratory (MBL), Woods Hole, MA, USA and Boston University Medical School, MA, USA, Martin Chalfie, Columbia University, New York, NY, USA and Roge ... more
A team of researchers in Bedford, Mass. has developed a way of examining brain tissue with near-infrared light to detect signs of Alzheimer's disease. In the March 15 issue of the journal Optics Letters, published by the Optical Society of America, the team describes how they used optical t ... more